Division of Hematology-Oncology, Department of Internal Medicine, Southern Illinois University School of Medicine (SIU), Springfield, IL 62794-9677, USA.
World J Surg Oncol. 2010 Jun 21;8:51. doi: 10.1186/1477-7819-8-51.
To date, the clinical presentation and prognosis of mixed ductal/lobular mammary carcinomas has not been well studied, and little is known about the outcome of this entity. Thus, best management practices remain undetermined due to a dearth of knowledge on this topic.
In this paper, we present a clinicopathologic analysis of patients at our institution with this entity and compare them to age-matched controls with purely invasive ductal carcinoma (IDC) and historical data from patients with purely lobular carcinoma and also stain-available tumor specimens for E-cadherin. We have obtained 100 cases of ductal and 50 cases of mixed ductal/lobular breast carcinoma.
Clinically, the behavior of mixed ductal/lobular tumors seemed to demonstrate some important differences from their ductal counterparts, particularly a lower rate of metastatic spread but with a much higher rate of second primary breast cancers.
Our data suggests that mixed ductal/lobular carcinomas are a distinct clinicopathologic entity incorporating some features of both lobular and ductal carcinomas and representing a pleomorphic variant of IDC.
迄今为止,混合性导管/小叶乳腺癌的临床表现和预后尚未得到很好的研究,对于这种肿瘤的结果知之甚少。因此,由于缺乏对这一课题的了解,最佳的管理实践仍未确定。
在本文中,我们对我院患有这种肿瘤的患者进行了临床病理分析,并将其与年龄匹配的单纯浸润性导管癌(IDC)对照组以及单纯小叶癌的历史数据进行了比较,同时还对可染色的肿瘤标本进行了 E-钙黏蛋白染色。我们获得了 100 例导管癌和 50 例混合性导管/小叶乳腺癌的标本。
临床上,混合性导管/小叶肿瘤的行为似乎与导管型肿瘤有一些重要的区别,特别是转移扩散率较低,但第二原发乳腺癌的发生率要高得多。
我们的数据表明,混合性导管/小叶癌是一种独特的临床病理实体,结合了小叶癌和导管癌的一些特征,代表了 IDC 的一种多形性变异。